Stock Price Forecast

Feb. 2, 2024


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading Nemaura Medical Inc chart...

About the Company

nemaura medical inc., a medical technology company, discovers, develops, and commercializes diagnostic medical devices. the company provides sugarbeat, a non-invasive continuous glucose monitoring device for use by persons with type i and type ii diabetes, as well as for screening pre-diabetic patients. it has a license agreement with healthimation, llc, which licenses the company to make, have made, use, offer to sell, sell, and import intensive medical diabetes and weight management program for type 2 diabetes, prediabetes, and general wellness; the why wait app; and common law trademarks which incorporate the mark why wait or whywait and the use of licensed marks. nemaura medical inc. was founded in 2009 and is based in new york, new york.

$0M

Total Revenue

6

Employees

$2M

Market Capitalization

-0.58

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $NMRD News

The Nemaura Medical (NASDAQ:NMRD) Share Price Is Down 63% So Some Shareholders Are Wishing They Sold

4y ago, source: Yahoo Finance

Nemaura Medical Inc. (NASDAQ:NMRD) shareholders should be happy to see the share price up 14% in the last week. But that's not enough to compensate for the decline over the last twelve months.

Nemaura Medical (NASDAQ: NMRD)

5d ago, source: The Motley Fool

Nemaura Medical, Inc. operates as a holding company. The firm engages in the provision of medical device research. It manufactures and commercializes glucose monitoring system, named sugarBEAT.

Nemaura Medical Inc N18A

17d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Nemaura Medical Reports Initial Patient Data from UK NHS Miboko Study that Demonstrates Weight Loss in 100% of Participants

1mon ago, source: ADVFN

Nemaura Medical, Inc. (NASDAQ: NMRD)(“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing non-invasive wearable sensors and supporting ...

Nasdaq Down Over 100 Points; Sidus Space Shares Spike Higher

on MSN ago, source:

Inc. (NASDAQ: ESPR) were down 21% to $2.2950 after the company announced a $125 million amendment to the collaboration with ...

Nemaura Medical Inc. (NMRD)

9d ago, source: Yahoo Finance

*Close price adjusted for splits.**Close price adjusted for splits and dividend and/or capital gain distributions. Loading more data ...

Form 8-K - Current report

25d ago, source: ADVFN

Item 5.07. Submission of Matters to a Vote of Security Holders. On February 26, 2024, Nemaura Medical Inc. (the “Company”) held its annual meeting of stockholders (the “Annual Meeting ...

VIVE Viveve Medical, Inc.

19h ago, source: Seeking Alpha

Viveve Medical, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices for the non-invasive treatment of vaginal introital laxity, sexual function ...

TNON Tenon Medical, Inc.

1d ago, source: Seeking Alpha

MHUAMeihua International Medical Technologies Co., Ltd.

Nasdaq Inc. Buy Rating: EPS Growth, Valuation Expansion, and Strong FinTech Prospects

2d ago, source:

In a report released today, Alexander Blostein from Goldman Sachs upgraded Nasdaq (NDAQ – Research Report) to a Buy, with a price target ...

Shockwave Medical Inc SWAV

3d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

iCAD, Inc. (ICAD)

1y ago, source: Yahoo Finance

Overall score is calculated based on proprietary scores based on sector averages in key company indicators: fair value, dividends, innovation, hiring, and insider sentiment. Note: if you don't see ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...